tiprankstipranks
Trending News
More News >
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market

TriSalus Life Sciences (TLSI) Income Statement

Compare
69 Followers

TriSalus Life Sciences Income Statement

Last quarter (Q3 2025), TriSalus Life Sciences's total revenue was $11.57M, an increase of 57.38% from the same quarter last year. In Q3, TriSalus Life Sciences's net income was $-10.81M. See TriSalus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 29.43M$ 18.51M$ 12.40M$ 8.40M$ 0.00
Gross Profit
$ 25.33M$ 15.91M$ 10.14M$ 7.21M$ 0.00
Operating Expenses
$ 61.49M$ 70.38M$ 46.58M$ 31.24M$ 108.49K
Depreciation and Amortization
$ -3.04M$ 684.00K$ 414.00K$ 464.00K$ 0.00
EBITDA
$ -36.16M$ -58.65M$ -46.76M$ -23.57M$ -711.39K
Operating Income
$ -36.16M$ -54.48M$ -36.44M$ -24.03M$ -108.49K
Other Income/Expenses
$ 6.13M$ -4.88M$ -10.74M$ -4.81M$ -602.90K
Pretax Income
$ -30.04M$ -59.35M$ -47.18M$ -28.84M$ -711.39K
Net Income
$ -33.23M$ -59.36M$ -47.19M$ -28.84M$ -31.83M
Per Share Metrics
Basic EPS
$ -1.25$ -2.23$ -1.59$ -0.92$ -0.02
Diluted EPS
$ -1.25$ -2.23$ -1.59$ -0.92$ -0.02
Weighted Average Shares Outstanding
26.50M 26.47M 29.61M 31.25M 30.56M
Weighted Average Shares Outstanding (Diluted)
26.50M 26.47M 29.61M 31.25M 30.56M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History